{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:24:57Z","timestamp":1786123497659,"version":"build-2736575974"},"reference-count":30,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":218,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Case Reports in Hematology"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>Cold agglutinin\u2013mediated autoimmune hemolytic anemia (AIHA) is a rare disorder in which IgM autoantibodies lead to complement\u2010dependent hemolysis and cold\u2010induced circulatory symptoms. It is categorized as either cold agglutinin disease (CAD), a primary lymphoproliferative disorder (LPD), or cold agglutinin syndrome (CAS), which occurs secondary to other conditions most commonly infections or lymphoid malignancies. Although the treatment for CAS should be directed toward the underlying condition, the often slower response rates of these treatments, especially in the setting of LPD, could necessitate other strategies for patients with severe hemolytic anemia requiring more rapid control of hemolysis. For patients with CAD, inhibition of the classical complement pathway with the C1s inhibitor sutimlimab has demonstrated significant control of hemolysis, resolution of anemia, and improvement in quality of life. However, little has been published regarding the use of sutimlimab for the treatment of CAS. Here, we describe a patient with CAS secondary to chronic lymphocytic leukemia (CLL) with severe IgM\u2010driven complement\u2010mediated hemolysis who was successfully treated with a combination of sutimlimab and CLL\u2010directed therapy with obinutuzumab\u2013venetoclax. Sutimlimab provided rapid cessation of hemolysis, acting as a bridge while the obinutuzumab\u2013venetoclax addressed the underlying CLL that was presumably responsible for the autoantibody production. This case demonstrates that combining sutimlimab with obinutuzumab\u2013venetoclax is an effective and safe treatment for patients with CAS in the setting of CLL, supporting the use of short\u2010term sutimlimab for CAS as a bridge to more durable treatment for underlying LPD such as CLL.<\/jats:p>","DOI":"10.1155\/crh\/9060134","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:20:33Z","timestamp":1786116033000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment of Cold Agglutinin Syndrome Secondary to Chronic Lymphocytic Leukemia With Sutimlimab and Obinutuzumab\u2013Venetoclax"],"prefix":"10.1155","volume":"2026","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6815-0695","authenticated-orcid":false,"given":"Coen J.","family":"Lap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1507-2851","authenticated-orcid":false,"given":"Catherine M.","family":"Broome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"e_1_2_11_1_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.282.6281.2023"},{"key":"e_1_2_11_2_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-02-474437"},{"key":"e_1_2_11_3_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015851"},{"key":"e_1_2_11_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01620-2"},{"key":"e_1_2_11_5_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V56.3.409.409"},{"key":"e_1_2_11_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-3886(00)00033-3"},{"key":"e_1_2_11_7_2","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2024.2366540"},{"key":"e_1_2_11_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2027760"},{"key":"e_1_2_11_9_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021014955"},{"key":"e_1_2_11_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0272-2712(18)30689-9"},{"key":"e_1_2_11_11_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13225804"},{"key":"e_1_2_11_12_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.036152"},{"key":"e_1_2_11_13_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.4.1216.1216"},{"key":"e_1_2_11_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0896-8411(88)90068-6"},{"key":"e_1_2_11_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-023-03608-9"},{"key":"e_1_2_11_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15063"},{"key":"e_1_2_11_17_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.186684"},{"key":"e_1_2_11_18_2","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2023.2218611"},{"key":"e_1_2_11_19_2","doi-asserted-by":"publisher","DOI":"10.2991\/chi.k.200706.001"},{"key":"e_1_2_11_20_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108547"},{"key":"e_1_2_11_21_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-10-3597"},{"key":"e_1_2_11_22_2","doi-asserted-by":"publisher","DOI":"10.1080\/10428190500286481"},{"key":"e_1_2_11_23_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-04-778175"},{"key":"e_1_2_11_24_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-06-288647"},{"key":"e_1_2_11_25_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021012039"},{"key":"e_1_2_11_26_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018024190"},{"key":"e_1_2_11_27_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1815281"},{"key":"e_1_2_11_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30262-2"},{"key":"e_1_2_11_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lrr.2024.100459"},{"key":"e_1_2_11_30_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2025.287410"}],"container-title":["Case Reports in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/crh\/9060134","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1155\/crh\/9060134","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/crh\/9060134","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:20:34Z","timestamp":1786116034000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/crh\/9060134"}},"subtitle":[],"editor":[{"given":"Kalyani","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1155\/crh\/9060134"],"URL":"https:\/\/doi.org\/10.1155\/crh\/9060134","archive":["Portico"],"relation":{},"ISSN":["2090-6560","2090-6579"],"issn-type":[{"value":"2090-6560","type":"print"},{"value":"2090-6579","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2026-01-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"9060134"}}